Different companies, different countries and different components are now at the center of the war on the Corona virus, but the goal of all of them is one: to find an effective vaccine for the virus, and as soon as possible. Experiments are already underway. So when will this happen?
243 vaccines are in development, 10 in advanced stages: it is not clear if and when this will happen and most importantly – for how many people will the vaccine be enough. So we went out to check what is currently in development and when is the long-awaited vaccine expected?
The vaccines of the American company Pfizer and of the German Biontech are expected in October at the earliest; Modern, expected in November and Johnson & Johnson and Nova-Vox, are expected by the end of the year. There is not enough information to determine if the vaccine is effective, and you should wait until the end of the experiment.
Meanwhile, a modern company has released information that shows that the vaccine is safe for use in adults, and produces antibodies in them in an amount similar to that observed in young people. The company is conducting the trial on 30,000 people in the United States to enable Phase 3.
Side effects included mild fever, headache, muscle aches, tremors, weakness, and pain in the injection site. Subjects described the side effects as moderate but there were also two more severe cases: one subject developed high fever, and another subject developed fatigue that disabled him from activity that day. In both cases the symptoms passed the next day. Other infected people had no side effects at all.
In China, on the other hand, there are no waiting and hundreds of thousands of people in the country have been vaccinated against the virus under the permit for emergency use, before the end of the third stage of safety and efficacy testing. Authorities there have reported no serious side effects, but experts doubt it.
Meanwhile, Etihad Cargo, the airline from the UAE, has launched a new pharma service. It has set up a dedicated distribution team to treat the virus that may be released to the United Arab Emirates as early as the end of 2021. It will be available at 54 stations on the same network: Abu Dhabi, Barcelona, Chicago, Paris, Dubai, Frankfurt, Hyderabad, London, Milan, Melbourne, Mumbai, Shanghai, Singapore and Sydney.
Another company, AstraZeneca, is currently conducting an experiment in the UK, but it was frozen after one patient suffered from a serious side effect that is still unclear if it was caused by the vaccine.
But now it turns out that the vaccine’s production capacity will allow only half of the population to be vaccinated by the end of 2021. In addition, the Sky News network reported that the attempt to develop the vaccine for Corona would involve the killing of about half a million sharks, the British. The vaccines that are currently in development contain the substance squalene, a natural oil that is produced, among other things, in the liver of sharks.
The use of squalene is common in the medical world, as an ingredient that enhances the effectiveness of preventative medicine treatments, by increasing the body’s immune response. About 3 million sharks are killed each year for the production of squalene, for the production of cosmetics and machine oil. Animal welfare organizations are furious and fear that the growing demand for the material will threaten the world’s shark population.
Source link by https://www.20il.co.il/%D7%94%D7%9E%D7%99%D7%A8%D7%95%D7%A5-%D7%9C%D7%97%D7%99%D7%A1%D7%95%D7%9F-%D7%9E%D7%AA%D7%99-%D7%A0%D7%A6%D7%9C%D7%99%D7%97-%D7%9C%D7%9E%D7%A6%D7%95%D7%90-%D7%90%D7%AA-%D7%94%D7%97%D7%99%D7%A1%D7%95/
*The article has been translated based on the content of Source link by https://www.20il.co.il/%D7%94%D7%9E%D7%99%D7%A8%D7%95%D7%A5-%D7%9C%D7%97%D7%99%D7%A1%D7%95%D7%9F-%D7%9E%D7%AA%D7%99-%D7%A0%D7%A6%D7%9C%D7%99%D7%97-%D7%9C%D7%9E%D7%A6%D7%95%D7%90-%D7%90%D7%AA-%D7%94%D7%97%D7%99%D7%A1%D7%95/
. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!